登录 注册 会员服务 联系我们

Epigenetic and breast cancer therapy: Promising diagnostic and therapeutic applications

  • Published:2020-08 Issue: Volume: Page:
  • ISSN:1044-579X
  • Container-title:Seminars in Cancer Biology
  • language:en
  • Short-container-title:Seminars in Cancer Biology

Author:

Sher Gulab,Salman Nadia Aziz,Khan Abdul Q.,Prabhu Kirti S.,Raza Afsheen,Kulinski Michal,Dermime Said,Haris Mohammad,Junejo Kulsoom,Uddin Shahab

Funder

Medical Research Center

Hamad Medical Corporation

Qatar National Library

Publisher

Elsevier BV

Subject

Cancer Research

Reference187 articles.

1. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods;Ferlay;Int. J. Cancer,2019

2. Global burden of breast cancer and attributable risk factors in 195 countries and territories, from 1990 to 2017: results from the Global Burden of Disease Study 2017;Li;J. Hematol. Oncol.,2019

3. WHO Report on Cancer: Setting Priorities, Investing Wisely and Providing Care for All,2020

4. Incidence and mortality and epidemiology of breast Cancer in the world;Ghoncheh;Asian Pac. J. Cancer Prev.,2016

5. Global Cancer in women: burden and trends;Torre;Cancer Epidemiol. Biomarkers Prev.,2017

Cited by 53 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3